LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-4.60 Cr | ₹-5.76 Cr | ₹-5.34 Cr | ₹9.90 Cr | ₹-3.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LYKA LABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-4.60 Cr |
| Mar2024 | ₹-5.76 Cr |
| Mar2023 | ₹-5.34 Cr |
| Mar2022 | ₹9.90 Cr |
| Mar2021 | ₹-3.15 Cr |
How is Net Cash Inflow / Outflow of LYKA LABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.60 Cr | Negative | |
| Mar2024 | ₹-5.76 Cr | Negative | |
| Mar2023 | ₹-5.34 Cr | Negative | |
| Mar2022 | ₹9.90 Cr | Positive | |
| Mar2021 | ₹-3.15 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹206.5 Cr | -4.7% | -19.1% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -4.7% |
-19.1% |
-40.2% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses